• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

川崎病患者静脉注射免疫球蛋白无反应性的预测

Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.

作者信息

Kobayashi Tohru, Inoue Yoshinari, Takeuchi Kazuo, Okada Yasunori, Tamura Kazushi, Tomomasa Takeshi, Kobayashi Tomio, Morikawa Akihiro

机构信息

Department of Pediatrics and Developmental Medicine, Gunma University Graduate School of Medicine, Gunma 377-8511, Japan.

出版信息

Circulation. 2006 Jun 6;113(22):2606-12. doi: 10.1161/CIRCULATIONAHA.105.592865. Epub 2006 May 30.

DOI:10.1161/CIRCULATIONAHA.105.592865
PMID:16735679
Abstract

BACKGROUND

In the present study, we developed models to predict unresponsiveness to intravenous immunoglobulin (IVIG) in Kawasaki disease (KD).

METHODS AND RESULTS

We reviewed clinical records of 546 consecutive KD patients (development dataset) and 204 subsequent KD patients (validation dataset). All received IVIG for treatment of KD. IVIG nonresponders were defined by fever persisting beyond 24 hours or recrudescent fever associated with KD symptoms after an afebrile period. A 7-variable logistic model was constructed, including day of illness at initial treatment, age in months, percentage of white blood cells representing neutrophils, platelet count, and serum aspartate aminotransferase, sodium, and C-reactive protein, which generated an area under the receiver-operating-characteristics curve of 0.84 and 0.90 for the development and validation datasets, respectively. Using both datasets, the 7 variables were used to generate a simple scoring model that gave an area under the receiver-operating-characteristics curve of 0.85. For a cutoff of 0.15 or more in the logistic regression model and 4 points or more in the simple scoring model, sensitivity and specificity were 86% and 67% in the logistic model and 86% and 68% in the simple scoring model. The kappa statistic is 0.67, indicating good agreement between the logistic and simple scoring models.

CONCLUSIONS

Our predictive models showed high sensitivity and specificity in identifying IVIG nonresponders among KD patients.

摘要

背景

在本研究中,我们开发了模型来预测川崎病(KD)患者对静脉注射免疫球蛋白(IVIG)无反应。

方法与结果

我们回顾了546例连续的KD患者(开发数据集)和204例后续KD患者(验证数据集)的临床记录。所有患者均接受IVIG治疗KD。IVIG无反应者定义为发热持续超过24小时或在无热期后出现与KD症状相关的再发发热。构建了一个包含初始治疗时的病程天数、月龄、代表中性粒细胞的白细胞百分比、血小板计数、血清天冬氨酸转氨酶、钠和C反应蛋白的7变量逻辑模型,该模型在开发数据集和验证数据集上的受试者操作特征曲线下面积分别为0.84和0.90。使用这两个数据集,这7个变量被用于生成一个简单评分模型,其受试者操作特征曲线下面积为0.85。对于逻辑回归模型中截断值为0.15或更高以及简单评分模型中截断值为4分或更高的情况,逻辑模型的敏感性和特异性分别为86%和67%,简单评分模型的敏感性和特异性分别为86%和68%。kappa统计量为0.67,表明逻辑模型和简单评分模型之间具有良好的一致性。

结论

我们的预测模型在识别KD患者中的IVIG无反应者方面显示出高敏感性和特异性。

相似文献

1
Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.川崎病患者静脉注射免疫球蛋白无反应性的预测
Circulation. 2006 Jun 6;113(22):2606-12. doi: 10.1161/CIRCULATIONAHA.105.592865. Epub 2006 May 30.
2
Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.日本川崎病患者对初始静脉注射免疫球蛋白治疗无反应的潜在风险因素分析。
Pediatr Infect Dis J. 2008 Feb;27(2):155-60. doi: 10.1097/INF.0b013e31815922b5.
3
Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.炎症细胞因子作为川崎病患者对静脉注射免疫球蛋白治疗抵抗的预测因子。
Int J Rheum Dis. 2013 Apr;16(2):168-72. doi: 10.1111/1756-185X.12082.
4
Risk factors and derived formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease.台湾川崎病患儿静脉注射免疫球蛋白无反应性的危险因素及衍生的福尔摩沙评分
J Formos Med Assoc. 2016 May;115(5):350-5. doi: 10.1016/j.jfma.2015.03.012. Epub 2015 Apr 21.
5
Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.川崎病患者早期静脉注射免疫球蛋白治疗。
J Pediatr. 2002 Apr;140(4):450-5. doi: 10.1067/mpd.2002.122469.
6
Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.川崎病患者静脉注射免疫球蛋白治疗耐药性的预测
J Pediatr. 2006 Aug;149(2):237-40. doi: 10.1016/j.jpeds.2006.03.050.
7
Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.用中等剂量(1克/千克)静脉注射免疫球蛋白治疗川崎病。
J Med Assoc Thai. 2002 Nov;85 Suppl 4:S1121-6.
8
An elevated value of high mobility group box 1 is a potential marker for poor response to high-dose of intravenous immunoglobulin treatment in patients with Kawasaki syndrome.
Pediatr Infect Dis J. 2009 Apr;28(4):339-41. doi: 10.1097/INF.0b013e31818ffe60.
9
Novel predictors of intravenous immunoglobulin resistance in Chinese children with Kawasaki disease.川崎病中国儿童静脉注射免疫球蛋白抵抗的新预测因子。
Pediatr Infect Dis J. 2013 Aug;32(8):e319-23. doi: 10.1097/INF.0b013e31828e887f.
10
Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease.静脉注射免疫球蛋白治疗后持续性单核细胞增多与川崎病患者冠状动脉病变的发生相关。
J Microbiol Immunol Infect. 2007 Oct;40(5):395-400.

引用本文的文献

1
Integrative machine learning and Mendelian randomization identify causal laboratory biomarkers for coronary artery lesions in Kawasaki disease: a prospective study.整合机器学习与孟德尔随机化方法确定川崎病冠状动脉病变的因果实验室生物标志物:一项前瞻性研究。
Front Genet. 2025 Aug 15;16:1646032. doi: 10.3389/fgene.2025.1646032. eCollection 2025.
2
Explainable deep learning algorithm for distinguishing IVIG-Resistant Kawasaki disease in Shandong peninsula, China.用于鉴别中国山东半岛IVIG无反应性川崎病的可解释深度学习算法
BMC Pediatr. 2025 Aug 28;25(1):658. doi: 10.1186/s12887-025-06082-w.
3
Association between C-reactive protein-albumin-lymphocyte (CALLY) index with intravenous immunoglobulin non-response in Kawasaki disease.
川崎病中C反应蛋白-白蛋白-淋巴细胞(CALLY)指数与静脉注射免疫球蛋白无反应性之间的关联
Ann Med. 2025 Dec;57(1):2548023. doi: 10.1080/07853890.2025.2548023. Epub 2025 Aug 20.
4
Immunophenotype of Kawasaki Disease: Insights into Pathogenesis and Treatment Response.川崎病的免疫表型:对发病机制和治疗反应的见解
Life (Basel). 2025 Jun 25;15(7):1012. doi: 10.3390/life15071012.
5
Prevalence of IVIG resistance in Kawasaki disease: a systematic review and meta-analysis.川崎病中静脉注射免疫球蛋白耐药的患病率:一项系统评价和荟萃分析。
Front Pediatr. 2025 Jul 4;13:1566590. doi: 10.3389/fped.2025.1566590. eCollection 2025.
6
Delineation of single-cell Altas provides new insights for development of coronary artery lesions in Kawasaki disease: bad and good signaling molecules.单细胞图谱的描绘为川崎病冠状动脉病变的发展提供了新见解:不良和良好的信号分子。
Front Pediatr. 2025 Jun 25;13:1596643. doi: 10.3389/fped.2025.1596643. eCollection 2025.
7
Predictive value of lymphocyte-to-C-reactive protein ratio for predicting initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease: a prospective cohort study.淋巴细胞与C反应蛋白比值对一大群川崎病患者初始及反复静脉注射免疫球蛋白抵抗的预测价值:一项前瞻性队列研究
Eur J Pediatr. 2025 Jul 9;184(8):472. doi: 10.1007/s00431-025-06296-1.
8
Heterogeneity in Kawasaki disease patients with coronary artery abnormalities investigated by data-driven cluster analysis.通过数据驱动的聚类分析研究川崎病合并冠状动脉异常患者的异质性。
Pediatr Res. 2025 Jun 20. doi: 10.1038/s41390-025-04205-8.
9
Interpretable web-based machine learning model for predicting intravenous immunoglobulin resistance in Kawasaki disease.用于预测川崎病静脉注射免疫球蛋白抵抗的基于网络的可解释机器学习模型。
Ital J Pediatr. 2025 Jun 9;51(1):181. doi: 10.1186/s13052-025-02036-1.
10
Risk factors associated with persistent coronary artery lesions in children with Kawasaki disease in an Italian cohort.意大利队列中川崎病患儿持续性冠状动脉病变的相关危险因素。
Eur J Pediatr. 2025 May 31;184(6):377. doi: 10.1007/s00431-025-06162-0.